Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease ; volume:270 ; number:11 ; day:8 ; month:8 ; year:2023 ; pages:5613-5621 ; date:11.2023
Journal of neurology ; 270, Heft 11 (8.8.2023), 5613-5621, 11.2023
- Creator
-
Angius, Fabrizio
Mocci, Ignazia
Ercoli, Tommaso
Loy, Francesco
Fadda, Laura
Palmas, Maria Francesca
Cannas, Giada
Manzin, Aldo
Defazio, Giovanni
Carta, Anna R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-023-11893-x
- URN
-
urn:nbn:de:101:1-2024010414074668998878
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Angius, Fabrizio
- Mocci, Ignazia
- Ercoli, Tommaso
- Loy, Francesco
- Fadda, Laura
- Palmas, Maria Francesca
- Cannas, Giada
- Manzin, Aldo
- Defazio, Giovanni
- Carta, Anna R.
- SpringerLink (Online service)
Other Objects (12)
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease